Recognition and management of depression in early psychosis. (April 2022)

• Record Type: Journal Article
• Authors: Bashir, Zainab; Griffiths, Sian Lowri; Upthegrove, Rachel
• Is Part Of: BJPsych bulletin. Volume 46:Number 2(2022)
• Page Start: 83
• Page End: 89
• Publication Date: 2022-04
• Subjects: Comorbidity -- psychotic disorders -- antidepressants -- depressive disorders -- early intervention; Psychiatry -- Periodicals; Psychiatry -- Great Britain -- Periodicals; 616.8905
• DOI: 10.1192/bjb.2021.15
• Languages: English
• ISSNs: 2056-4694

Abstract

Abstract : Aims and method: Depression in first-episode psychosis (FEP) is highly prevalent and associated with poor outcomes; it has become increasingly recognised and adopted in national and international guidelines for psychosis. Using a 26-item questionnaire, this study aimed to explore if this shift has led to greater recognition among UK psychiatrists, and more effective management of depression in FEP. Results: Of the 297 respondents, 54.4% observed depression occurring in chronic psychosis, with the least number of respondents (17.7%) identifying depression occurring frequently during FEP. Although there was reasonable agreement in the use of antidepressants as a first-line treatment for depression (70% prescribing antidepressants), there was uncertainty around assessing depression and delineating from psychosis symptoms, and particularly negative symptoms. Clinical implications: Evidence-based treatments for comorbid depression in psychosis will lead to clearer national guidelines, allowing for optimal management of depression in early psychosis, potentially leading to improved outcomes for these individuals.